Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aptamer:toxin conjugates that specifically target prostate tumor cells.

Ted C Chu1, John W Marks, Laura A Lavery

  • 1Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas 78712, USA.

Cancer Research
|June 17, 2006
PubMed
Summary

RNA aptamer:gelonin conjugates effectively target and destroy cancer cells overexpressing prostate-specific membrane antigen (PSMA). This targeted therapy shows significantly enhanced potency and reduced toxicity in non-target cells, validating escort aptamers for tumor treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Agnostic material classification using differential de Bruijn graphs of DNA imprints.

bioRxiv : the preprint server for biology·2026
Same author

The Origin of Life in the Light of Evolution.

ArXiv·2026
Same author

Overestimating zero-shot fitness prediction: Broad benchmarks mask local failures and practical limitations.

bioRxiv : the preprint server for biology·2026
Same author

Integrating Transcription Factors with Electrochemical Pendulum Bioanalysis for Hormone Detection.

Journal of the American Chemical Society·2026
Same author

Fieldable isothermal nucleic acid test for rapid semi-quantitative visual readout of enterococci in recreational waters.

PeerJ·2026
Same author

Uncertainty of Fit - Serving People with Borderline Personality Disorder on an Assertive Community Treatment Team Setting: Experiences and Perspectives of Clinicians from a Flexible ACT Team.

Community mental health journal·2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Prostate-specific membrane antigen (PSMA) is a cancer biomarker overexpressed in certain tumors.
  • Targeted cancer therapies aim to selectively eliminate cancer cells while sparing healthy ones.

Purpose of the Study:

  • To investigate the efficacy of RNA aptamer:gelonin conjugates in targeting and destroying PSMA-overexpressing cells.
  • To evaluate the potency and specificity of these aptamer:toxin conjugates.

Main Methods:

  • Conjugation of RNA aptamers with the toxin gelonin.
  • Treatment of cell lines with varying PSMA expression levels using the aptamer:toxin conjugates.
  • Assessment of cell viability and toxicity.

Main Results:

Related Experiment Videos

  • Aptamer:gelonin conjugates demonstrated an IC50 of 27 nmol/L.
  • Potency was increased at least 600-fold in PSMA-expressing cells compared to non-expressing cells.
  • The aptamer facilitated cellular uptake and reduced gelonin toxicity in non-target cells.

Conclusions:

  • RNA aptamer:gelonin conjugates are effective in selectively targeting and eliminating PSMA-positive cancer cells.
  • "Escort aptamers" show promise as a therapeutic strategy for specific tumors expressing unique antigen targets.